advertisement

Topcon

Figueiredo A 14

Showing records 1 to 14 | Display all abstracts from Figueiredo A

92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Marta A
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Baptista PM; Vieira R
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Vieira R
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Vieira R
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Vieira R; Figueiredo A
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Ferreira A; Figueiredo A
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Reis R
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Sampaio I
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Sampaio I
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Sampaio I
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Sampaio I
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Reis R
Clinical Ophthalmology 2021; 15: 1061-1071
92599 Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis
Beirão JM; Menéres MJ
Eye 2022; 36: 111-118
92627 The Role of Multimodal Approach in the Assessment of Glaucomatous Damage in High Myopes
Menéres MJ
Clinical Ophthalmology 2021; 15: 1061-1071

Issue 22-1

Change Issue


advertisement

Oculus